← All organizations

CellMed AG

For profit

Highest phase reached

Phase 1

First clinical trial

Sep 1, 2010

Last known activity

Sep 1, 2010

Acquired by BTGBoston Scientific Corporation on Mar 8, 2005

Timeline

2000s

  1. Jun 1, 2000

    CellMed AG— Founded

  2. Jun 7, 2004

    NewBiotics— Acquired

  3. Mar 8, 2005

    BTGBTG— Acquired By

2010s

  1. Nov 20, 2018

    Boston Scientific Corporation— Now

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (0 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (1)

Details

Founded
Alzenau, DE Jun 1, 2000
Last known activity
Sep 1, 2010